|
ATAD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.8016000014629E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.158300E-03 |
| Normal-vs-Stage2 |
9.994400E-02 |
| Normal-vs-Stage3 |
9.66829999999863E-05 |
| Normal-vs-Stage4 |
3.136300E-02 |
| Stage1-vs-Stage2 |
3.874600E-01 |
| Stage1-vs-Stage3 |
9.989300E-04 |
| Stage1-vs-Stage4 |
7.317700E-02 |
| Stage2-vs-Stage3 |
2.872400E-02 |
| Stage2-vs-Stage4 |
1.057780E-01 |
| Stage3-vs-Stage4 |
8.863800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.5067099999988E-05 |
| Normal-vs-AfricanAmerican |
5.715400E-03 |
| Normal-vs-Asian |
3.412100E-02 |
| Caucasian-vs-AfricanAmerican |
5.499200E-01 |
| Caucasian-vs-Asian |
2.315600E-01 |
| AfricanAmerican-vs-Asian |
7.546100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.217300E-04 |
| Normal-vs-Female |
1.78830999999491E-05 |
| Male-vs-Female |
2.123700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.798400E-03 |
| Normal-vs-Extreme_Weight |
3.928300E-02 |
| Normal-vs-Obese |
1.003060E-03 |
| Normal-vs-Extreme_Obese |
4.794200E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.169370E-01 |
| Normal_Weight-vs-Obese |
2.999000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.360900E-03 |
| Extreme_Weight-vs-Obese |
1.290110E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.806500E-02 |
| Obese-vs-Extreme_Obese |
7.751600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.478050E-02 |
| Normal-vs-Age(41-60Yrs) |
7.02469999946942E-07 |
| Normal-vs-Age(61-80Yrs) |
4.381600E-03 |
| Normal-vs-Age(81-100Yrs) |
2.140800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.379500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.462400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.226000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.976300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.276800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.471800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.378020E-02 |
| Normal-VS-Type2 PRCC |
3.431600E-04 |
| Normal-VS-KIRP CIMP |
2.004700E-03 |
| Normal-VS-Unclassified PRCC |
7.195600E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.915900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.700500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.238220E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.460800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.647800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.982500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.317620E-02 |
| Normal-vs-N1 |
3.611300E-04 |
| Normal-vs-N2 |
1.549590E-01 |
| N0-vs-N1 |
2.864000E-03 |
| N0-vs-N2 |
2.314000E-01 |
| N1-vs-N2 |
8.873200E-01 |
|
|
